According to a media statement by Pfizer, the company will be closing its Singapore Pfizer Clinical Research Unit (PCRU) in 2013.
The decision was made as part of Pfizer Worldwide Research & Development’s ongoing comprehensive effort to increase operational efficiencies and to create a more focused and sustainable R&D engine. Full story
